There are many funding opportunities that support the conduct of rigorous, cutting-edge dissemination and implementation research at the National Cancer Institute (NCI) and across the National Institutes of Health (NIH). The most prominent funding opportunity is the Trans-NIH program announcement with special receipt, referral and/or review (PAR), Dissemination and Implementation Research in Health. NCI, along with many other participating institutes and centers across the NIH, issued this PAR for R03, R21 and/or R01 funding mechanisms. Below, we provide additional information about this implementation science (IS) funding opportunity as well as resources for prospective IS applicants.
- Trans-NIH PAR, Dissemination and Implementation Research in Health
- R01, Dissemination and Implementation Research in Health
- R21, Dissemination and Implementation Research in Health
- Note: The R21 exploratory/developmental grant mechanism supports investigation of novel scientific ideas or new model systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. An R21 grant application need not have extensive background material or preliminary information. Preliminary data are not required for R21 applications; however, they may be included if available.
- R03, Dissemination and Implementation Research in Health
- Note: The R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Because the research project usually is limited, an R03 grant application may not contain extensive detail or discussion. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies.